GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GelStat Corp (OTCPK:GSAC) » Definitions » Operating Income

GelStat (GelStat) Operating Income : $-0.42 Mil (TTM As of Dec. 2008)


View and export this data going back to 1996. Start your Free Trial

What is GelStat Operating Income?

GelStat's Operating Income for the three months ended in Dec. 2008 was $-0.09 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2008 was $-0.42 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. GelStat's Operating Income for the three months ended in Dec. 2008 was $-0.09 Mil. GelStat's Revenue for the three months ended in Dec. 2008 was $0.01 Mil. Therefore, GelStat's Operating Margin % for the quarter that ended in Dec. 2008 was -1,740.00%.

GelStat's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. GelStat's annualized ROC % for the quarter that ended in Dec. 2008 was -59.08%. GelStat's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2008 was %.


GelStat Operating Income Historical Data

The historical data trend for GelStat's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GelStat Operating Income Chart

GelStat Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.87 -3.72 -1.76 -1.04 -0.42

GelStat Quarterly Data
Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.25 -0.13 -0.13 -0.07 -0.09

GelStat Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GelStat  (OTCPK:GSAC) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

GelStat's annualized ROC % for the quarter that ended in Dec. 2008 is calculated as:

ROC % (Q: Dec. 2008 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2008 ) + Invested Capital (Q: Dec. 2008 ))/ count )
=-0.348 * ( 1 - 0% )/( (0.498 + 0.68)/ 2 )
=-0.348/0.589
=-59.08 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2008) data.

2. Joel Greenblatt's definition of Return on Capital:

GelStat's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2008 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2008 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2008  Q: Dec. 2008
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.348/( ( (0 + max(-1.703, 0)) + (0 + max(-1.753, 0)) )/ 2 )
=-0.348/( ( 0 + 0 )/ 2 )
=-0.348/0
= %

where Working Capital is:

Working Capital(Q: Sep. 2008 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.002 + 0 + 0.02) - (1.725 + 0 + 0)
=-1.703

Working Capital(Q: Dec. 2008 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.02) - (1.578 + 0.115 + 0.08)
=-1.753

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2008) EBIT data.

3. Operating Income is also linked to Operating Margin %:

GelStat's Operating Margin % for the quarter that ended in Dec. 2008 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2008 )/Revenue (Q: Dec. 2008 )
=-0.087/0.005
=-1,740.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


GelStat Operating Income Related Terms

Thank you for viewing the detailed overview of GelStat's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


GelStat (GelStat) Business Description

Traded in Other Exchanges
N/A
Address
333 SE 2nd Avenue, Suite 2000, Miami, FL, USA, 33131
GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.
Executives
Adrian Graham Goldfarb director 7660 CENTURION PARKWAY, SUITE 100, JACKSONVILLE FL 32256
Donald Miller director, officer: Chief Financial Officer
Garry N Lowenthal officer: Chief Financial Officer 2551 38TH AVENUE NE, STE 135, MINNEAPOLIS MN 55421

GelStat (GelStat) Headlines

No Headlines